Cargando…

Hybrid SARS-CoV-2 variants

Detalles Bibliográficos
Autores principales:	Rahimi, Farid, Talebi Bezmin Abadi, Amin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IJS Publishing Group Ltd. Published by Elsevier Ltd. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9074379/ https://www.ncbi.nlm.nih.gov/pubmed/35533853 http://dx.doi.org/10.1016/j.ijsu.2022.106656

Ejemplares similares

Challenges of managing the asymptomatic carriers of SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

Detection of the XE subvariant of SARS-CoV-2: A perspective
por: Rahimi, Farid, et al.
Publicado: (2022)

Implications of the SARS-CoV-2 subvariants BA.4 and BA.5
por: Rahimi, Farid, et al.
Publicado: (2022)

Emergence of the Omicron SARS-CoV-2 subvariants during the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

Highly contagious but less severe COVID-19 caused by new SARS-CoV-2 sublineages may abate the pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

Omicron: A highly transmissible SARS-CoV-2 variant
por: Rahimi, Farid, et al.
Publicado: (2022)

Emergence of the Delta Plus variant of SARS-CoV-2 in Iran
por: Rahimi, Farid, et al.
Publicado: (2021)

Implications of the Emergence of a New Variant of SARS-CoV-2, VUI-202012/01
por: Rahimi, Farid, et al.
Publicado: (2021)

SARS-CoV-2 Lambda (C.37): An emerging variant of concern?
por: Darvishi, Mohammad, et al.
Publicado: (2021)

The third booster vaccination dose against COVID-19: indication for circulating SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2021)

A Commentary on “Omicron SARS-CoV-2 variant: Reasons of emergence and lessons learnt” (Int J Surg 2022;97:106198) Contact-tracing and global vaccine equity: Crucial responses to emergence of the Omicron SARS-CoV-2 variant
por: Rahimi, Farid, et al.
Publicado: (2022)

Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2
por: Rahimi, Farid, et al.
Publicado: (2020)

‘The end’ – or is it? Emergence of SARS-CoV-2 EG.5 and BA.2.86 subvariants
por: Rahimi, Farid, et al.
Publicado: (2023)

The Omicron subvariant BA.2: Birth of a new challenge during the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2022)

WHO prequalified tocilizumab and vaccine boosters against COVID-19
por: Rahimi, Farid, et al.
Publicado: (2022)

The Ukrainian refugee crisis and the COVID-19 pandemic in Europe
por: Rahimi, Farid, et al.
Publicado: (2022)

COVID-19 and science diplomacy
por: Rahimi, Farid, et al.
Publicado: (2022)

The 2022 monkeypox outbreak: Lessons from the 640 cases in 36 countries
por: Rahimi, Farid, et al.
Publicado: (2022)

Corrigendum to ‘Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2’[Arch. Med. Res. 51(5) (2020) 453–454/ARCMED 2020 432]
por: Rahimi, Farid, et al.
Publicado: (2023)

Immediate countermeasures against the monkeypox outbreak
por: Rahimi, Farid, et al.
Publicado: (2022)

Comment on “Gastric cancer and family history”
por: Abadi, Amin Talebi Bezmin
Publicado: (2017)

The Mu strain: the last but not least circulating ‘variant of interest’ potentially affecting the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2021)

Simultaneous occurrence of seasonal influenza virus and SARS CoV-2 strains
por: Talebi Bezmin Abadi, A., et al.
Publicado: (2021)

Simultaneous occurrence of seasonal influenza virus and SARS CoV-2 strains
por: Talebi Bezmin Abadi, A., et al.
Publicado: (2021)

Practical Strategies Against the Novel Coronavirus and COVID-19—the Imminent Global Threat
por: Rahimi, Farid, et al.
Publicado: (2020)

Comment on “circSMARCA5 Functions as a Diagnostic and Prognostic Biomarker for Gastric Cancer”
por: Rahimi, Farid, et al.
Publicado: (2019)

Tackling the COVID-19 Pandemic
por: Rahimi, Farid, et al.
Publicado: (2020)

Transparency and information sharing could help abate the COVID-19 pandemic
por: Rahimi, Farid, et al.
Publicado: (2020)

Identification of Streptococcus gallolyticus in tumor samples of Iranian patients diagnosed with colorectal cancer
por: Kamali, Negin, et al.
Publicado: (2022)

Colonization by Pseudomonas aeruginosa and Staphylococcus aureus of Antral Biopsy Specimens from Gastritis Patients Uninfected with Helicobacter Pylori
por: Kachuei, Vida, et al.
Publicado: (2020)

Where is the next SARS-CoV-2 variant of concern?
por: Dennehy, John J, et al.
Publicado: (2022)

Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization
por: Wang, Guo-Lin, et al.
Publicado: (2021)

The impact of SARS-CoV-2 variants on IBD management
por: Segal, Jonathan P, et al.
Publicado: (2021)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Type 2 diabetes and Helicobacter pylori infection: Starting point for the reality?
por: Abadi, Amin Talebi Bezmin
Publicado: (2015)

Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants
por: Evans, John P., et al.
Publicado: (2022)

Rapid identification and tracking of SARS-CoV-2 variants of concern
por: Chakraborty, Debojyoti, et al.
Publicado: (2021)

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark
por: Bager, Peter, et al.
Publicado: (2021)

SARS-CoV-2 rapid diagnostic tests for emerging variants
por: Bekliz, Meriem, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c5gokv2gm9o27nlh7qa862ie91